-
Featured
Asthma Not Associated with Poorer Outcomes in Hospitalized COVID-19 Patients
Massachusetts General Hospital researchers found that inpatients with COVID-19 who had asthma were less likely than COVID-19 inpatients without asthma to require ICU admission or mechanical ventilation and were not at increased risk of death.
-
Research Reveals Novel Molecular Mechanisms Specific to Allergic Asthma
Researchers at Massachusetts General Hospital combine advanced techniques to identify novel pathways and cell interactions associated with allergic asthma.
-
Acid Suppressant Therapy in Infancy Linked to Increased Risk of Childhood Respiratory Conditions
Lacey B. Robinson, MD, MPH, Carlos A. Camargo, Jr., MD, DrPH, and colleagues studied children with a history of severe bronchiolitis who were treated with acid suppressant medications during infancy, finding their risk of developing recurrent wheeze and asthma in early childhood was nearly doubled.
-
Discovering the Pathways That Lead to Allergic Asthma
Jehan Alladina, MD, and colleagues of the Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital, are using an innovative in vivo research method to study allergic asthma pathogenesis.
-
Differences in Measuring Endotoxin Explains Contradictory Results on Lung Health Effects
Molly Wolf, MD, and Peggy S. Lai, MD, MPH, of the Division of Pulmonary and Critical Care Medicine, explain that common methods of quantifying microbial exposure have inherent limitations, which probably explain the contradictory evidence on whether microbial exposure harms lung health.
-
Maximizing Clinical Utility of Pulmonary Optical Imaging
Massachusetts General Hospital researchers push the limits of pulmonary optical frequency domain imaging for in vivo diagnosis of lung cancer and assessment of asthmatic airways.
Asthma Contributors
-
David Adams, PhD
Instructor in Medicine, Massachusetts General Hospital
Recent Article
Endobronchial OCT Useful for Assessing Airway Remodeling and Function in Asthma -
Kimberly G. Blumenthal, MD, MSc
Director of Research, Drug and Vaccine Allergy Center , Co-Director, Clinical Epidemiology Program, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Assistant Professor of Medicine, Harvard Medical School
Recent Article
Novel Schema Classifies Allergy-related Safety Events in Healthcare Settings
-
Melissa J. Suter, PhD
Associate Professor in Medicine, Harvard Medical School, Assistant in Biomedical Engineering, Massachusetts General Hospital
Recent Article
Maximizing Clinical Utility of Pulmonary Optical Imaging -
Molly Wolf, MD
Pulmonary and Critical Care Fellow, Massachusetts General Hospital
Recent Article
BMI Not Associated With Meaningful Differences in COVID-19 Critical Illness Outcomes -
Peggy S. Lai, MD, MPH
Physician-Scientist, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Assistant Professor of Medicine, Harvard Medical School
Recent Article
Supplemental Oxygen Alters the Airway Microbiome in Cystic Fibrosis
Pulmonary and Critical Care Medicine
The Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital provides comprehensive care for the full range of respiratory conditions and diseases.